LONDON (Reuters) - Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, ...
Read more
LONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay ...
Read more
LONDON (Reuters) - GlaxoSmithKline is discussing the sale of its thrombosis drug brands Arixtra and Fraxiparine, along with a related French factory, to Aspen Pharmacare in a deal that could ...
Read more
LONDON (Reuters) - One of the world's longest running drug development sagas may draw to a close this month as French firm Sanofi hopes for a European green light for ...
Read more
LONDON (Reuters) - Genomics and particle physics - offering different perspectives on the fundamental nature of life and the cosmos - are the two hottest areas of scientific research.Eight of ...
Read more
LONDON (Reuters) - AstraZeneca has decided to end development of fostamatinib, a rheumatoid arthritis pill that was one of its few late-stage experimental medicines, following disappointing overall results.The decision is ...
Read more
LONDON (Reuters) - AstraZeneca is to buy Omthera Pharmaceuticals for as much as $443 million to build up its cardiovascular drug business, a priority area for Britain's second-biggest drugmaker.The acquisition ...
Read more
LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers ...
Read more
LONDON (Reuters) - Is nanomedicine the next big thing? A growing number of top drug companies seem to think so.The ability to encapsulate potent drugs in tiny particles measuring billionths ...
Read more
LONDON (Reuters) - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favoring the two U.S. companies.The ...
Read more
LONDON (Reuters) - Governments on both sides of the Atlantic are placing big new bets on the future of brain science, just as much of the pharmaceutical industry retreats from ...
Read more
LONDON/MUMBAI (Reuters) - Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to ...
Read more
LONDON (Reuters) - British scientists have developed a new vaccine against foot-and-mouth disease that is safer and easier to manufacture, an advance they believe should greatly increase production capacity and ...
Read more
LONDON (Reuters) - Europe's financial crisis is costing lives, with suicides and infectious diseases on the rise, yet politicians are not addressing the problem, health experts said on Wednesday. Deep ...
Read more
LONDON (Reuters) - The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to ...
Read more
